+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma



The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma



European Journal of Cancer 49(2): 377-385



The aim of this study was to determine whether C-reactive protein (CRP) levels or patient's comorbidity before treatment predicted the overall disease-specific survival and local tumour control in high grade soft tissue sarcoma patients. A total of 332 primary adult soft tissue sarcoma patients were retrospectively reviewed. CRP levels were obtained prior to treatment for all patients. The Charlson comorbidity index (CCI) was used for evaluation as a measure of comorbidity. Patients that presented with metastases at diagnosis were excluded from this study. Elevated CRP levels were seen in 152 patients. CCI score varied from 0 to 4. Two-hundred and sixty-five patients had a score of 0 (no identified comorbidity), and 67 patients had a score of 1 or more. Patients with elevated CRP levels prior to initial treatment had a poorer disease-specific survival (42% at 5 years) than patients with normal CRP levels (82% at 5 years) (p<0.0001). Patients with elevated CRP levels had a poorer local recurrence-free rate after initial treatment (75% at 5 years) than patients with normal CRP levels (89% at 5 years) (p=0.0004). Multivariate analysis also showed the preoperative CRP level to be an independent predictor of survival and local control. Although age in patients with identified comorbidity was significantly higher than those in patients with no-identified comorbidity, CCI was not a predictive factor for either survival or local control. Pretreatment elevated CRP levels were found to be a poor prognostic factor for disease-specific survival and local control for soft tissue sarcoma patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056532007

Download citation: RISBibTeXText

PMID: 23058786

DOI: 10.1016/j.ejca.2012.09.004


Related references

The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma. Tumour Biology 36(10): 7515-7520, 2015

Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103(2): 402-408, 2005

Prediction of survival in patients with high-grade soft tissue sarcoma. International Orthopaedics 14(2): 199-204, 1990

Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma. Surgical Oncology 27(4): 695-701, 2018

Interaction of histologic type and grade in predicting survival from soft tissue sarcoma. Journal of Clinical Oncology 26(15_Suppl): 10530-10530, 2016

The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Bone and Joint Journal 97-B(6): 847-852, 2015

Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study. Cancer 51(3): 396-401, 1983

Comparison between a 2- and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma. Journal of Surgical Oncology 72(2): 77-82, 1999

Long-term survival in high-grade soft-tissue sarcoma - prognostic factors in synovial sarcoma. International Journal of Oncology 7(1): 161-169, 1995

Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma. Medicine 94(28): E1142, 2015

Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall. Asia-Pacific Journal of Clinical Oncology 14(2): E109-E115, 2018

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER. Cancer Medicine 7(9): 4228-4239, 2018

Survival of patients with soft tissue sarcoma (STS) correlated to tumor grade, size, site of origin & cell type. Does the high risk group need adjuvant systemic therapy?. Journal of Clinical Oncology 24(18_Suppl): 19510-19510, 2016

Factors predicting survival of patients with retroperitoneal soft-tissue sarcoma; does surgical experience influence survival?. European Journal of Cancer 37(Suppl. 6): S85-S86, 2001

Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary?. Annals of Surgical Oncology 8(6): 484-495, 2001